Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
checkpoint inhibitors
Marketing
Docs ask pharma for more NSCLC drugs, resources and research
Oncologists want more therapies, more resources for managing patients of color and more research into managing comorbidities.
Nick Paul Taylor
Jan 25, 2024 6:30am
Roche hits FDA delay with subcutaneous Tecentriq
Sep 7, 2023 2:46pm
GSK beats Merck to first PD-1 approval in 1L endometrial cancer
Jul 31, 2023 2:33pm
Merck's Keytruda flunks trial in early stomach cancer
Jun 20, 2023 11:28am
'The Top Line': BIO's conference, plus this week's headlines
Jun 16, 2023 6:00am
ASCO: Can Keytruda expand further in first-line cervical cancer?
May 25, 2023 5:00pm